Home › ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development
 

Keywords :   


ACADIA Pharmaceuticals Announces Advancement By Allergan Of Novel Glaucoma Compound Into Preclinical Development

2013-06-03 11:00:00| drugdiscoveryonline News Articles

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that Allergan, Inc. has advanced an additional product candidate as a potential new treatment for glaucoma

Tags: development compound announces pharmaceuticals

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »